Results of a Pilot Study of a Mail-Based Human Papillomavirus Self-Testing Program for Underscreened Women From Appalachian Ohio.


Journal

Sexually transmitted diseases
ISSN: 1537-4521
Titre abrégé: Sex Transm Dis
Pays: United States
ID NLM: 7705941

Informations de publication

Date de publication:
03 2019
Historique:
pubmed: 22 11 2018
medline: 27 2 2020
entrez: 22 11 2018
Statut: ppublish

Résumé

Human papillomavirus (HPV) self-testing is an emerging cervical cancer screening strategy, yet few mail-based HPV self-testing programs have been implemented in the United States. We report the results of a pilot study of a mail-based program, the Health Outcomes through Motivation and Education Project. In 2015 to 2016, we recruited 103 women from Appalachian Ohio who were aged 30 to 65 years and had not received a Papanicolaou (Pap) test in at least 3 years. Women were mailed an HPV self-test and randomized to receive either (a) self-test instructions developed by the device manufacturer and a standard information brochure about cervical cancer (control group) or (b) self-test instructions developed by the Health Outcomes through Motivation and Education Project and a photo story information brochure about cervical cancer (intervention group). Logistic regression compared study arms on HPV self-test return and receipt of a Pap test. Overall, 80 (78%) women returned their HPV self-test. Return was similar among the intervention and control groups (78% vs. 77%; odds ratio, 1.09; 95% confidence interval, 0.43-2.76). Among returners, 26% had an oncogenic HPV type detected in their sample. Women who returned their self-test reported high levels of satisfaction and positive experiences with the self-testing process. Few women overall received a Pap test (11%), and Pap testing was similar among the intervention and control groups (14% vs. 8%; odds ratio, 1.91; 95% confidence interval, 0.52-6.97). Mail-based HPV self-testing programs are a potentially promising strategy for reaching underscreened women in Appalachia. Efforts are needed to better understand how to optimize the success of such programs.

Sections du résumé

BACKGROUND
Human papillomavirus (HPV) self-testing is an emerging cervical cancer screening strategy, yet few mail-based HPV self-testing programs have been implemented in the United States. We report the results of a pilot study of a mail-based program, the Health Outcomes through Motivation and Education Project.
METHODS
In 2015 to 2016, we recruited 103 women from Appalachian Ohio who were aged 30 to 65 years and had not received a Papanicolaou (Pap) test in at least 3 years. Women were mailed an HPV self-test and randomized to receive either (a) self-test instructions developed by the device manufacturer and a standard information brochure about cervical cancer (control group) or (b) self-test instructions developed by the Health Outcomes through Motivation and Education Project and a photo story information brochure about cervical cancer (intervention group). Logistic regression compared study arms on HPV self-test return and receipt of a Pap test.
RESULTS
Overall, 80 (78%) women returned their HPV self-test. Return was similar among the intervention and control groups (78% vs. 77%; odds ratio, 1.09; 95% confidence interval, 0.43-2.76). Among returners, 26% had an oncogenic HPV type detected in their sample. Women who returned their self-test reported high levels of satisfaction and positive experiences with the self-testing process. Few women overall received a Pap test (11%), and Pap testing was similar among the intervention and control groups (14% vs. 8%; odds ratio, 1.91; 95% confidence interval, 0.52-6.97).
CONCLUSIONS
Mail-based HPV self-testing programs are a potentially promising strategy for reaching underscreened women in Appalachia. Efforts are needed to better understand how to optimize the success of such programs.

Identifiants

pubmed: 30461597
doi: 10.1097/OLQ.0000000000000944
pmc: PMC6370501
mid: NIHMS1512342
doi:

Banques de données

ClinicalTrials.gov
['NCT02460237']

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

185-190

Subventions

Organisme : NCI NIH HHS
ID : P30 CA016058
Pays : United States

Références

Hum Vaccin Immunother. 2013 Jan;9(1):90-6
pubmed: 23143774
Cancer. 2008 Nov 15;113(10 Suppl):3036-46
pubmed: 18980286
J Womens Health (Larchmt). 2016 May;25(5):489-97
pubmed: 26598955
Sex Transm Dis. 2018 Jan;45(1):42-48
pubmed: 28876298
Med J Aust. 2016 Mar 21;204(5):1941e-7
pubmed: 26985849
Cancer Epidemiol Biomarkers Prev. 2015 May;24(5):769-72
pubmed: 25713024
Women Health. 2017 Nov-Dec;57(10):1161-1177
pubmed: 27700693
Sex Transm Infect. 2011 Mar;87(2):118-22
pubmed: 21115503
J Natl Cancer Inst. 2012 Feb 8;104(3):178-88
pubmed: 22271765
Gynecol Oncol. 2014 Mar;132 Suppl 1:S21-5
pubmed: 24125753
Eur J Cancer. 2015 Nov;51(16):2375-85
pubmed: 26296294
J Community Health. 2015 Jun;40(3):379-86
pubmed: 25257565
CA Cancer J Clin. 2012 May-Jun;62(3):147-72
pubmed: 22422631
Can J Public Health. 2009 Sep-Oct;100(5):365-9
pubmed: 19994740
BMC Cancer. 2016 Mar 15;16:221
pubmed: 26979237
Can J Public Health. 2013 Feb 11;104(2):e159-66
pubmed: 23618210
J Fam Plann Reprod Health Care. 2015 Oct;41(4):259-64
pubmed: 25385868
J Immigr Minor Health. 2013 Apr;15(2):398-406
pubmed: 22485012
Can Fam Physician. 2017 Aug;63(8):597-601
pubmed: 28807952
Lancet Oncol. 2014 Feb;15(2):172-83
pubmed: 24433684
BMC Cancer. 2015 Nov 04;15:849
pubmed: 26536865
Front Oncol. 2016 Jan 28;6:2
pubmed: 26858934
Womens Health Issues. 2013 Mar-Apr;23(2):e123-30
pubmed: 23410619

Auteurs

Deborah McDonough (D)

Valley View Health Centers, Waverly, OH.

Mack T Ruffin (MT)

Department of Family and Community Medicine, Penn State Hershey Medical Center, Hershey, PA.

Martin Steinau (M)

Division of Global HIV and TB, Center for Global Health, and.

Elizabeth R Unger (ER)

Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH